Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human CYP1B1 ELISA Kit (AC2456)
Cat.#: ASET-1045
Specifications
Description Human CYP1B1 ELISA Kit allows for the in vitro quantitative determination of human CYP1B1 concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.094 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 0.156-10 ng/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-2238 Mouse Rilpl2 ELISA Kit (AC3649) Quantitative inquiry ASET-1998 Human Vaspin ELISA Kit (AC3409) Quantitative inquiry ASET-2391 Human CRF ELISA Kit (AC3802) Quantitative inquiry ASET-1005 Rat Hes1 ELISA Kit (AC2416) Quantitative inquiry ASET-1767 Human Neurokinin B Receptor ELISA Kit (AC3178) Quantitative inquiry ASET-1470 Human GCH1 ELISA Kit (AC2881) Quantitative inquiry ASET-1248 Rat Cathepsin G ELISA Kit (AC2659) Quantitative inquiry ASET-1013 Human HAS1 ELISA Kit (AC2424) Quantitative inquiry ASET-2327 Human NRP2 ELISA Kit (AC3738) Quantitative inquiry ASET-2321 Mouse Dehydroepiandrosterone ELISA Kit (AC3732) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket